Uso de una composicion que comprende un compuesto contra el receptor de egf y un compuesto contra el gangliosido neugcgm3 para tratar cancer; y kit utilizado que comprende dichos compuestos

The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical composit...

Full description

Saved in:
Bibliographic Details
Main Authors LEON MONZON KALET, BLANCO SANTANA RANCES, GONZALEZ PALOMO ADYS, CARR PEREZ ADRIANA, BARROSO ALVAREZ MARIA DEL CARMEN, MONTERO CASIMIRO JOSE ENRIQUE, MACIAS ABRAHAM AMPARO EMILIA
Format Patent
LanguageSpanish
Published 08.08.2014
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.
Bibliography:Application Number: CL20140001236